Philippe joined AnaSpec in 2011. He brings 15 years of experience in the Pharmaceutical and Life Science Industry together with a broad scientific background. He joined the parent company Eurogentec in 2005 as the Director of the Biologics Contract Manufacturing Unit. In 2008, he took the position of Chief Scientific Officer, heading the Research and Development activities of the company. Prior to Eurogentec, he worked at AstraZeneca where he was heading a team supplying target proteins in the drug discovery process. Philippe carried out his PhD in the field of protein engineering and bioinformatics at the EMBL-Heidelberg.

 

Masanobu joined AnaSpec as Vice President of Operations in 2011. Prior to joining AnaSpec, he served as Integration Officer at the parent company, Eurogentec S.A. after the company became a member of Kaneka Corporation, a Japanese Chemical Industry in 2010. From 1999 to 2010 he worked at Kaneka (Osaka, Japan) where he was engaged in R&D process chemistry and new business development for pharmaceutical intermediates. He was also responsible for strategic planning including M&A. Masanobu received his PhD in the field of synthetic organic chemistry, organometallics, electro-organic chemistry at Kyoto University, Japan.

 

Ralph joined AnaSpec in 2012. He brings over 15 years of business development experience to AnaSpec. Previously, Ralph has worked in various business development roles for Roche, and several contract manufacturers with specialty peptide and protein active pharmaceutical ingredient manufacturing capabilities. Ralph is also a founder of the Boulder Peptide Symposium. Along with his team, Ralph enjoys working with customers to enable their basic research and to help advance their clinical studies focused on the development of therapeutics.